| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
April 9,
2026 |
| Accession Number: |
0001213900-26-040545 |
| Submission Type: |
POS AM |
| CIK: |
0001139685 |
| Company Name: |
20/20 Biolabs, Inc. |
| File Number: |
333-292125 |
|
